The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 237 of the 241 references it cites were found in a registry or an index.
Abstract
Objective: To develop clinical practice guidelines for the management of patients with primary aldosteronism. Participants: The Task Force included a chair, selected by the Clinical Guidelines Subcommittee of the Endocrine Society, six additional experts, a methodologist, and a medical writer. The guideline was cosponsored by American Heart Association, American Association of Endocrine Surgeons, European Society of Endocrinology, European Society of Hypertension, International Association of Endocrine Surgeons, International Society of Endocrinology, International Society of Hypertension, Japan Endocrine Society, and The Japanese Society of Hypertension. The Task Force received no corporate funding or remuneration. Evidence: We searched for systematic reviews and primary studies to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation group criteria to describe both the quality of evidence and the strength of recommendations. We used “recommend” for strong recommendations and “suggest” for weak recommendations. Consensus Process: We achieved consensus by collecting the best available evidence and conducting one group meeting, several conference calls, and multiple e-mail communications. With the help of a medical writer, the Endocrine Society's Clinical Guidelines Subcommittee, Clinical Affairs Core Committee, and Council successfully reviewed the drafts prepared by the Task Force. We placed the version approved by the Clinical Guidelines Subcommittee and Clinical Affairs Core Committee on the Endocrine Society's website for comments by members. At each stage of review, the Task Force received written comments and incorporated necessary changes. Conclusions: For high-risk groups of hypertensive patients and those with hypokalemia, we recommend case detection of primary aldosteronism by determining the aldosterone-renin ratio under standard conditions and recommend that a commonly used confirmatory test should confirm/exclude the condition. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend that an experienced radiologist should establish/exclude unilateral primary aldosteronism using bilateral adrenal venous sampling, and if confirmed, this should optimally be treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia or those unsuitable for surgery should be treated primarily with a mineralocorticoid receptor antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Algorithm for the detection, confirmation, subtype testing, and treatment of PA. a We recommend unilateral laparoscopic adrenalectomy for patients with documented unilateral PA (ie, APA or UAH) (1 ⎪ QQQE ). If a patient is unable or unwilling to undergo surgery, we recommend medical treatment including a MR antagonist (1 ⎪ QQQE ). If an ARR-positive patient is unwilling or unable to undergo further investigations, we similarly recommend medical treatment including an MR antagonist (1 ⎪ QQEE ). b Instead of proceeding directly to subtype classification, we recommend that patients with a positive ARR undergo one or more confirmatory tests to definitively confirm or exclude the diagnosis (1 ⎪ QQEE ). However, in the setting of spontaneous hypokalemia, undetectable renin, and PAC > 20 ng/dL (550 pmol/L), we suggest that there may be no need for further confirmatory testing (2 ⎪ QEEE ). c We recommend that when surgical treatment is feasible and desired by the patient, an experienced radiologist should use AVS to make the distinction between unilateral and bilateral adrenal disease (1 ⎪ QQQE ). Younger patients ( < age 35) with spontaneous hypokalemia, marked aldosterone excess, and unilateral adrenal lesions with radiological features consistent with a cortical adenoma on adrenal CT scan may not need AVS before proceeding to unilateral adrenalectomy (2 ⎪ QEEE ). [Adapted from J. W. Funder et al: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab . 2008;93:3266-3281 (3), with permission. © Endocrine Society.]](https://figures.cochat.ai/paper-figures/aaade82f5c4b425bbdee69e74321806d/the-management-of-primary-aldosteronism-case-detection-diagnosis-and-treatment-figure-1.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common types of secondary hypertension in adults are renal parenchymal disease, renovascular hypertension, primary aldosteronism, chronic sleep apnea, and substance/drug-induced.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A specific cause of secondary hypertension can be identified in 5%-10% of hypertensive patients (Table 11).”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early diagnosis of secondary hypertension and the institution of appropriate targeted treatment have the potential to cure hypertension in some patients or improve BP control/reduce the number of prescribed antihypertensive medications in others.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypokalemia, which reduces aldosterone secretion, should be corrected with oral K+ supplements before testing.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [289]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with unilateral disease (50%; aldosterone-producing adenoma or, much less frequently, unilateral hyperplasia) respond to unilateral laparoscopic adrenalectomy with complete cure (≈50%) or improvement (≈50%) in BP control.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [289]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–237 of 237
Review of surgical management of aldosterone secreting tumours of the adrenal cortex
Harris, D. A., Au-Yong, I., Basnyat, P. S., Sadler, G. P., & Wheeler, M. H. (2003) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(03)00051-9 · Cited by 63 · cited 1×
“Other factors that have been reported to predict cure, but have only been evaluated by univariate analysis or when the cutoff for BP resolution was 160/95 mm Hg (44, 161), include: duration of hypertension 5 years (44, 45, 80, 81), higher PAC: PRA ratio preoperatively (80, 81), higher urinary aldosterone secretion (80…”
BackgroundGlucocorticoid-remediable Aldosteronism
Halperin, F., & Dluhy, R. G. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.012 · Cited by 62
Ori, Y., Chagnac, A., Korzets, A., Zingerman, B. V., Herman‐Edelstein, M., Bergman, M., Gafter, U., & Salman, H. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs587 · Cited by 62 · cited 1×
“There is strong evidence linking improved BP control and/or reduction in aldosterone lev-Table els to improved cardiac and cerebrovascular outcomes (33– 37) and quality of life (38).”
BackgroundClinical Study of Adrenal Incidentaloma in Korea
Kim, H. Y., Kim, S. G., Lee, K. W., Seo, J. A., Kim, N. H., Choi, K. M., Baik, S. H., & Choi, D. S. (2005) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2005.20.4.303 · Cited by 62 · cited 1×
“of aldosterone and possibly cell proliferation (35, 141).”
BackgroundConventional Imaging in Adrenocortical Carcinoma: Update and Perspectives
Young, W. F. (2011) · Hormones and Cancer · doi:10.1007/s12672-011-0089-z · Cited by 60 · cited 2×
“Aldoste-rone-producing adrenal carcinomas are almost always (cid:2) 4 cm in diameter, but occasionally smaller, and like most adrenocortical carcinomas have a suspicious imaging phenotype on CT (51, 74).”
BackgroundSelf-citationUmakoshi, H., Tanase‐Nakao, K., Wada, N., Ichijo, T., Sone, M., Inagaki, N., Katabami, T., Kamemura, K., Matsuda, Y., Fujii, Y., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12761 · Cited by 58 · cited 1×
“The contralateral suppression of aldosterone secretion has recently been reported to be helpful in the diagnosis of unilateral PA (109, 110).”
BackgroundPrognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study
Miyake, Y., Tanaka, K., Nishikawa, T., Naruse, M., Takayanagi, R., Sasano, H., Takeda, Y., Shibata, H., Sone, M., Satoh, F., et al. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0353 · Cited by 56 · cited 1×
“A recent nationwide survey in Japan showed that surgical therapy improved both hypertension and hypokalemia more than medical therapy in unilateral and/or bilateral aldosterone-producing adenomas; one possible caveat is that eplerenone was not used in the survey (160).”
BackgroundSelf-citationMansoor, G. A., Malchoff, C. D., Arici, M. H., KARIMEDDINI, M. K., & Whalen, G. F. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02312-3 · Cited by 53 · cited 1×
“findings obtained with high-resolution CT (121) and”
Sze, W.-C., Soh, L. M., Lau, J. H. G., Reznek, R. H., Sahdev, A., Matson, M. B., Riddoch, F., Carpenter, R., Berney, D. M., Grossman, A. B., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12374 · Cited by 52 · cited 1×
“However, the utility of these three criteria was not reproducible in two recently published studies (100, 102).”
BackgroundStowasser, M., Klemm, S. A., Tunny, T. J., Storie, W. J., Rutherford, J. C., & Gordon, R. D. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02520.x · Cited by 52
Self-citationMantero, F., Fallo, F., Opocher, G., Armanini, D., Boscaro, M., & Scaroni, C. M. (1981) · Clinical Science · doi:10.1042/cs061289s · Cited by 51 · cited 11×
“Radiologists might interpret small APAs incorrectly as “IAH” on the basis of CT findings of bilateral nodularity or normal-appearing adrenals.”
BackgroundInfluentialSelf-citationLaparoscopic versus open adrenalectomy for surgical adrenal disease.
Jacobsen, N.-E., Campbell, J. B., & HOBART, M. G. (2003) · PubMed · Cited by 51
Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit, S., Bernheim, J., & Podjarny, E. (2002) · PubMed · Cited by 50
Helber, A., Wambach, G. K., Hummerich, W., B�nner, G., Meurer, K. A., & Kaufmann, W. (1980) · Journal of Molecular Medicine · doi:10.1007/bf01476798 · Cited by 49
Confirmatory Tests in the Diagnosis of Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Mengozzi, G., Tizzani, D., Iannaccone, A., & Veglio, F. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246186 · Cited by 48 · cited 1×
“et al (62, 63), who reported a satisfactory agreement be-”
BackgroundRe‐evaluation of the captopril test for the diagnosis of primary hyperaldosteronism
Hambling, C., Jung, R. T., Gunn, A., Browning, M. C. K., & Bartlett, W. A. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02252.x · Cited by 46
Fardella, C., Pinto, M. P., Mosso, L. M., Gómez-Sánchez, C. E., Jalil, J., & Montero, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7920 · Cited by 46 · cited 1×
“Genetic testing by either Southern blot (131) or long PCR (132) techniques for the underlying hybrid CYP11B1/ CYP11B2 mutation is sensitive and specific for GRA and should replace indirect testing (eg, urinary levels of 18oxocortisol and 18-hydroxy-cortisol, or dexamethasone suppression testing), both of which may be…”
MethodFarquharson, C. A. J. (2002) · Heart · doi:10.1136/heart.88.5.475 · Cited by 46 · cited 1×
“It lacks the sex steroid-related side effects of spironolactone but does not provide the beneficial effects on endothelial function (195, 196).”
BackgroundMinami, I., Yoshimoto, T., Hirono, Y., Izumiyama, H., Doi, M., & Hirata, Y. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-164 · Cited by 45
Reardon, M. A., Angle, J. F., Abi‐Jaoudeh, N., Bruns, D. E., Haverstick, D. M., Matsumoto, A. H., & Carey, R. M. (2011) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2011.05.005 · Cited by 44 · cited 1×
“Some centers perform AVS in all patients who have the diagnosis of PA (89, 94).”
BackgroundSelf-citationDiagnosis and Treatment of Primary Aldosteronism
Rossi, G. P. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.005 · Cited by 40
Gates, L. J., Benjamin, N., Haites, N. E., MacConnachie, A., & McLay, J. (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001152 · Cited by 39 · cited 1×
“PA patients with a family history of PA or of strokes at a young age (130, 134), or with onset at a young age (eg, 20 years).”
BackgroundAdrenal vein sampling: Substantial need for technical improvement at regional referral centres
Elliott, P., & Holmes, D. T. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.04.004 · Cited by 38 · cited 1×
“Many groups advocate the use of continuous cosyntropin infusion during AVS to: 1) minimize stress-induced fluctuations in aldosterone secretion during nonsimultaneous (sequential) AVS; 2) maximize the gradient in cortisol from adrenal vein to inferior vena cava and thus confirm successful sampling of the adrenal vein…”
The management of aldosterone-producing adrenal adenomas—does adrenalectomy increase costs?
Reimel, B., Zanocco, K. A., Russo, M. J., Zarnegar, R., Clark, O. H., Allendorf, J., Chabot, J. A., Duh, Q., Lee, J. A., & Sturgeon, C. (2010) · Surgery · doi:10.1016/j.surg.2010.09.012 · Cited by 37
Kater, C. E., Biglieri, E. G., Schambelan, M., & Arteaga, E. (1983) · Hypertension · doi:10.1161/01.hyp.5.6_pt_3.v115 · Cited by 37
Solař, M., Malířová, E., Ballon, M., Pelouch, R., & Ceral, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0914 · Cited by 36 · cited 2×
“control BP during confirmatory testing (66).”
Willenberg, H. S., Vonend, O., Schott, M., Gao, X., Blondin, D., Saleh, A., Rump, L. C., & Scherbaum, W. A. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1314786 · Cited by 35 · cited 2×
“Finally, Willenberg et al (61) reported divergent results between the SIT and FST and also found a lower cutoff value for SIT than FST; this was in contrast with Mulatero et al (62, 63), who reported a satisfactory agreement be-tween the two tests.”
ResultRhamy, R. K., McCoy, R. M., Scott, H. W., Fishman, L. M., Michelakis, A. M., & Liddle, G. W. (1968) · Annals of Surgery · doi:10.1097/00000658-196805000-00010 · Cited by 35
Efficacy of adrenal venous sampling is increased by point of care cortisol analysis
Viste, K., Grytaas, M. A., Jørstad, M. D., Jøssang, D. E., Høyden, E. N., Fotland, S. S., Jensen, D., Løvås, K., Thordarson, H. B., Almås, B., et al. (2013) · Endocrine Connections · doi:10.1530/ec-13-0063 · Cited by 24
Spironolactone and Amiloride in the Treatment of Low Renin Hyperaldosteronism and Related Syndromes
Kremer, D., Beevers, D. G., Brown, J. J., Davies, D. L., Ferriss, J. B., Fräser, R., Lever, A. F., & Robertson, J. I. (1973) · Clinical Science · doi:10.1042/cs045213s · Cited by 24
[Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
Omura, M., & Nishikawa, T. (2006) · PubMed · Cited by 23
PRIMARY ALDOSTERONISM: SURGICAL MANAGEMENT AND PATHOLOGIC FINDINGS
Priestley, J. T., Ferris, D. O., ReMine, W. H., & Woolner, L. B. (1968) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(26)01633-2 · Cited by 21
Diagnostic investigations in primary aldosteronism
Gordon, R. D. (2001) · Cited by 20
Left ventricular changes in primary aldosteronism
Rossi, G. P. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03021-2 · Cited by 19 · cited 1×
“Such studies showed increased left ventricular (LV) dimensions and myocardial fibrosis (150–152), increased carotid intima-media thickness (153, 154), and increased femoral pulse wave velocity and reduced endothelial function (155).”
BackgroundSpironolacton bei essentieller Hypertonie mit gestörter Aldosteron-Regulation und bei Conn-Syndrom
Wambach, G. K., Helber, A., Bönner, G., Hummerich, W., Meurer, K. A., & Kaufmann, W. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1070723 · Cited by 14
Primary Hyperaldosteronism and Other Forms of Mineralocorticoid Hypertension
Parthasarathy, H. K., & MacDonald, T. M. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50070-2 · Cited by 14
Gunnells, J. C. (1967) · Archives of Internal Medicine · doi:10.1001/archinte.1967.00300040052009 · Cited by 13
Research works printed but not linked: 3
- 15. Tucker RM, Labarthe DR. Frequency of surgical treatment for hypertensioninadultsattheMayoClinicfrom1973through1975. Mayo Clin Proc . 1977;52:549-545.
- 133. FardellaCE,PintoM,MossoL,Gómez-SánchezC,JalilJ,Montero J. Genetic study of patients with dexamethasone-suppressible aldosteronismwithoutthechimericCYP11B1/CYP11B2gene. J Clin Endocrinol Metab . 2001;86:4805-4807.
- 169. Jacobsen NE, Campbell JB, Hobart MG. Laparoscopic versus openadrenalectomyforsurgicaladrenaldisease. CanJUrol . 2003; 10:1995-1999.
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Self-citation2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., Blowey, D., Carroll, A. E., Daniels, S. R., de Ferranti, S. D., Dionne, J. M., Falkner, B., Flinn, S. K., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1904 · Cited by 3,651
Metadata
- Authors
- Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F.
- Affiliations
- Hudson Institute of Medical Research (AU)
- University of Virginia Health System (US)
- University of Padua (IT)
- Mayo Clinic (US)
- Klinikum of the Ludwig-Maximilians-University of Munich (M.R.), 80366 München, Bavaria, Germany
- Oita University (JP)
- The University of Queensland (AU)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-05-01
- Volume
- 101
- Issue
- 5
- Pages
- 1889-1916
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2290633895
- Semantic Scholar
- 36716f26ebd3b8e468f352d9132208c41e5688c0
- Cited by
- 2,925
- References
- 241
- Citations by year
- 2026: 236 · 2025: 397 · 2024: 315 · 2023: 329 · 2022: 329 · 2021: 315 · 2020: 293 · 2019: 238 · 2018: 200 · 2017: 188 · 2016: 72
- FWCI
- 233.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, adrenal computed tomography, adrenal vein sampling, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Adrenal Glands, Adrenalectomy, Aldosterone, Mineralocorticoid Receptor Antagonists, Humans, Hyperaldosteronism, Renin, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.